Compare Motilal Oswal Nifty MidSmall Healthcare Index Fund vs ICICI Prudential Healthcare Fund
Motilal Oswal Nifty MidSmall Healthcare Index Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.21
2.07
NAV
₹11.68
₹44.12
Fund Started
29 Oct 2024
25 Jun 2018
Fund Size
₹52.54 Cr
₹6861.20 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
7.93%
-0.15%
3 Year
-
19.01%
5 Year
-
14.29%
Equity
100.07%
98.91%
Cash
-0.07%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Laurus Labs Ltd. | 11.83% |
Lupin Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 7.09% |
Fortis Healthcare Ltd. | 6.15% |
Glenmark Pharmaceuticals Ltd. | 5.39% |
Alkem Laboratories Ltd. | 4.78% |
Mankind Pharma Ltd. | 4.35% |
Ipca Laboratories Ltd. | 4.11% |
Biocon Ltd. | 3.96% |
Gland Pharma Ltd. | 3.54% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
29 Oct 2024
25 Jun 2018
